These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 2757893)

  • 1. Bioavailability of hydroxychloroquine tablets in healthy volunteers.
    Tett SE; Cutler DJ; Day RO; Brown KF
    Br J Clin Pharmacol; 1989 Jun; 27(6):771-9. PubMed ID: 2757893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques.
    Tett SE; Cutler DJ; Day RO
    J Pharm Sci; 1992 Feb; 81(2):155-9. PubMed ID: 1545355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis.
    McLachlan AJ; Tett SE; Cutler DJ; Day RO
    Br J Rheumatol; 1994 Mar; 33(3):235-9. PubMed ID: 8156285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and in vivo dissolution of hydroxycholoroquine in fed subjects assessed using deconvolution techniques.
    McLachlan AJ; Tett SE; Cutler DJ; Day RO
    Br J Clin Pharmacol; 1993 Nov; 36(5):405-11. PubMed ID: 12959287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.
    Tett SE; Cutler DJ; Day RO; Brown KF
    Br J Clin Pharmacol; 1988 Sep; 26(3):303-13. PubMed ID: 3179169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine relative bioavailability: within subject reproducibility.
    Tett S; Day R; Cutler D
    Br J Clin Pharmacol; 1996 Mar; 41(3):244-6. PubMed ID: 8866926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.
    Furst DE
    Lupus; 1996 Jun; 5 Suppl 1():S11-5. PubMed ID: 8803904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability study of cefixime administered as tablets or aqueous solution.
    Montay G; Masala F; Le Roux Y; Le Liboux A; Uhlrich J; Chassard D; Thebault JJ; Roche G; Frydman A
    Drugs; 1991; 42 Suppl 4():6-9. PubMed ID: 1725153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state pharmacokinetics of hydroxychloroquine in rheumatoid arthritis patients.
    Miller DR; Khalil SK; Nygard GA
    DICP; 1991 Dec; 25(12):1302-5. PubMed ID: 1815421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
    Kendall J; Papich MG
    Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate.
    McLachlan AJ; Tett SE; Cutler DJ; Day RO
    Chirality; 1994; 6(4):360-4. PubMed ID: 8068494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of slow-acting antirheumatic drugs.
    Tett SE
    Clin Pharmacokinet; 1993 Nov; 25(5):392-407. PubMed ID: 7904547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the stereoisomers of hydroxychloroquine and its major metabolites in plasma and urine following a single oral administration of racemic hydroxychloroquine.
    Iredale J; Fieger H; Wainer IW
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):74-81. PubMed ID: 8278822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ; Beal J; Day RO; Tett SE
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.